iRhythm Technologies, Inc. (IRTC)

Market Cap	3.45B
Revenue (ttm)	560.03M
Net Income (ttm)	-150.66M
Shares Out	31.30M
EPS (ttm)	-4.85
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	273,954
Open	112.00
Previous Close	112.02
Day's Range	109.96 - 112.85
52-Week Range	55.92 - 124.12
Beta	1.26
Analysts	Strong Buy
Price Target	107.80 (-2.3%)
Earnings Date	Feb 20, 2025

About IRTC

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 20, 2016
• Employees: 2,000
• Stock Exchange: NASDAQ
• Ticker Symbol: IRTC
• Website: https://www.irhythmtech.com

Financial Performance

In 2023, iRhythm Technologies's revenue was $492.68 million, an increase of 19.90% compared to the previous year's $410.92 million. Losses were -$123.41 million, 6.24% more than in 2022.

Analyst Forecast

According to 10 analysts, the average rating for IRTC stock is "Strong Buy." The 12-month stock price forecast is $107.8, which is a decrease of -2.30% from the latest price.

Price Target

$107.8

(-2.30% downside)

Analyst Consensus: Strong Buy